CEACAM5 and colorectal cancer: Furthermore, somatic missense mutations in colorectal cancers have been detected in CEACAM1 (Song et al., 2011) and CEACAM5 (Gu et al., 2020), the latter of which has been shown to increase proliferation by inhibiting TGFB signaling and altering the intestinal microbiome.